The effect of cardiopulmonary bypass on the lung: the injured pulmonary vascular endothelium

Kirklin JK , Westaby S. , Blackstone EH , Kirklin JW , Chenoweth DE , Pacifico AD Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 86: 845-57.

Smith Eej , Naftel DC , Blackstone EH , Kirklin JW Microvascular permeability after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1987; 94 225-33.

Breckenridge IM , Digerness SB , Kirklin JW Increased extracellular fluid after open intracardiac operation. Surg Gynecol Obstet 1970; 131: 53-56.

Parker DJ , Karp RB , Kirklin JW , Bedard P. Lung water and alveolar and capillary volumes after intracardiac surgery . Circulation 1972; 45 (suppl 1): 139-46.

Turner-Sharp J. , Griffith GT , Bunnell IL , Greene DG Ventilatory mechanics in pulmonary edema in man. J Clin Invest 1958 ; 37: 111-17.

Ellison LT , Duke JF , Ellison RG Pulmonary compliance following open-heart surgery and its relationship to ventilation and gas exchange. Circulation 1967; 35 (suppl I): 217-25.

Heard GG , Lamberti JJ , Park SM , Waldman JD , Waldman J. Early extubation after surgical repair of congenital heart disease . Crit Care Med 1985; 13: 830-32.

Kanter RK , Bove EL , Tobin JR , Zimmerman JJ Prolonged mechanical ventilation of infants after open heart surgery . Crit Care Med 1986; 14: 211-14.

Ratliff NB , Young WG Jr , Hackel DB , Mikat E. , Wilson JW Pulmonary injury secondary to extracorporeal circulation. J Thorac Cardiovasc Surg 1973;65:425-32.

Asada S. , Yamaguchi M. Fine structural change in the lung following cardiopulmonary bypass . Chest 1971; 59:478-83.

Panossian A. , Hagstrom Jwc , Nehlsen SL , Veith FJ Secondary nature of surfactant changes in postperfusion pulmonary damage. J Thorac Cardiovasc Surg 1969; 57: 628-34.

Sobonya RE , Kleinerman J. , Primiano F. , Chester EH Pulmonary changes in cardiopulmonary bypass: short-term effects on granular pneumocytes. Chest 1972; 61: 154-58.

Haworth SG Pulmonary vascular remodelling in neonatal pulmonary hypertension . State of the art. Chest 1988; 93: 133-38S.

Hall SM , Haworth SG Onset and evolution of pulmonary vascular disease in young children: abnormal postnatal remodelling studied in lung biopsies. J Pathol 1992; 166: 183-93.

Jones Odh , Shore DF , Rigby ML et al. The use of tolazoline hydrochloride as a pulmonary vasodilator in potentially fatal episodes of pulmonary vasoconstriction after cardiac surgery in children. Circulation 1981; 64 (suppl II): 134-39.

Hopkins RA , Bull C. , Haworth SG , DeLeval MR , Stark J. Pulmonary hypertensive crises following surgery for congenital heart defects in young children. Eur J Cardiothorac Surg 1991; 5: 628-34.

Sole MJ , Drobac M. , Schwartz L. , Hussain MN , Vaughan-Neil EF The extraction of circulating catecholamines by the lungs in normal man and in patients with pulmonary hypertension. Circulation 1979; 60: 160-63.

Gillis CN , Huxtable RJ , Roth RA Effect of monocrotaline pretreatment of rats on removal of 5-hydroxytryptamine and noradrenaline by perfused lung. Br J Pharmacol 1978; 63: 435-43.

Gillis CN , Cronau LH , Greene NM , Hammond GL Removal of 5-hydroxytryptamine and norephinephrine from the pulmonary vascular space of man: influence of cardiopulmonary bypass and pulmonary arterial pressure on these processes. Surgery 1974; 76: 608-16.

Reves JG , Karp RB , Buttner EE et al. Neuronal and adrenomedullary catecholamine release in response to cardiopulmonary bypass in man. Circulation 1982; 66: 49-55.

Minami K. , Körner MM , Vyska K. , Kleesiek K. , Knobl H. , Körfer R. Effects of pulsatile perfusion on plasma catecholamine levels and hemodynamics during and after cardiac operations with cardiopulmonary bypass . J Thorac Cardiovasc Surg 1990; 99: 82-91.

Yanagisawa M. , Kurihara H. , Kimura S. et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-15.

Adatia I. , Haworth SG Endothelin in pulmonary hypertensive congenital heart disease. Am Rev Respir Dis 1991; 143: A403.

Komai H. , Adatia IT , Elliott MJ , DeLeval MR , Haworth SG Increased endothelin plasma levels following cardiopulmonary bypass in congential heart disease. Am Rev Respir Dis 1992; 145: A641.

Johnson AR Human pulmonary endothelial cells in culture. J Clin Invest 1980; 65: 841-50.

Ingerman-Wojenski C. , Silver MJ , Smith JB , Macarak E. Bovine endothelial cells in culture produce thromboxane as well as prostacyclin. J Clin Invest 1981 ;67:1292-96.

Adatia IT , Barrow SE , Ritter JM , Haworth SG Advanced pulmonary vascular disease: evidence of reduced prostacyclin production . Circulation 1990; 82 (suppl III): 100.

Faymonville M. , Deby-Dupont G. , Larbuisson R. , Bodson Cdl , Limet R. , Lany M. Prostaglandin E2, prostacyclin, and thomboxane changes during nonpulsatile cardiopulmonary bypass in humans. J Thorac Cardiovasc Surg 1986; 91: 858-66.

Greeley WJ , Bushman GA , Kong DL , Oldman HN , Peterson MB Effects of cardiopulmonary bypass on eicosanoid metabolism during pediatric cardiovascular surgery. J Thorac Cardiovasc Surg 1988; 95: 842-49.

Pitt BR , Lister G. , Gillis CN Hemodynamic effects on lung metabolic function. In: Ryan US ed. Pulmonary endothelium in health and disease . New York: Marcel Dekker , 1987: 65-87.

Bonser RS , Dave JR , Davies ET et al. Reduction of complement activation during bypass by prime manipulation . Ann Thorac Surg 1990; 49: 279-83.

Tenneberg SD , Bailey WW , Cotta LA , Brodt JK , Solomkin JS The effects of methylprednisolone on complement-mediated neutrophil activation during cardiopulmonary bypass. Surgery 1986; 100: 134-42.

van Oeveren W. , Harder MP , Roozendaal KJ , Eijsman L. , Wildevuur Crh. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1990; 99: 788-97.

Blauhut B. , Gross C. , Necek S. , Doran JE , Späth P. , Lundsgaard-Hansen P. Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1991;101: 958-67.

Cavarocchi NC , Schaff HV , Orszulak TA , Homburger HA , Schnell WA , Pluth JR Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass. Surgery 1985 ; 98: 525-30.

Menasché P. , Antebi H. , Alcindor L. et al. Iron chelation by deferoxamine inhibits lipid peroxidation during cardiopulmonary bypass in humans. Circulation 1990; 82 (suppl IV): 390-96.

Ohtani M. , Matsuda H. , Shirakura R. et al. Attenuation of pulmonary leukocyte sequestration during extracorporeal circulation by a new c-AMP phosphodiesterase inhibitor. ASAIO Trans 1988; 34: 761-64.

Gu YJ , Wang YS , Chiang BY , Gao XD , Ye CX , Wildevuur RH Reduction of granulocyte-mediated lung injury in canine cardiopulmonary bypass by anisodamine infusion. Thorac Cardiovasc Surg 1991; 39: 154-157.

Doerschuk CM , Winn RK , Coxson HO , Harlan JM CD 18-dependent and independent mechanisms of neutrophil emigration in the pulmonary and systemic microcirculation of rabbits. J Immunol 1990 ; 144: 2327-33.

Kaslovsky RA , Horgan MJ , Lum H. , McCandles BK , Gilboa N. , Wright SD , Malik AB Pulmonary edema induced by phagocytosing neutrophils. Circ Res 1990; 67: 795-802.

Horgan MJ , Wright SD , Malik AB Antibody against leukocyte integrin (CD18) prevents reperfusion-induced lung vascular injury. Am J Physiol 1990; 259: L315-19.

Bando K. , Pillai R. , Cameron DE et al. Leukocyte depletion ameliorates free radical-mediated lung injury after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1990; 99: 873-77.

Davies GG , Wells DG , Mabee TM , Sadler R. , Melling NJ Platelet-leukocyte plasmaphaeresis attenuates the deleterious effects of cardiopulmonary bypass. Ann Thorac Surg 1992; 53: 274-77.

Moncada S. , Radomski MW , Palmer Rmj. Endothelium-derived relaxing factor: identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol 1988; 37: 2495-2501.

Pepka-Zaba J. , Higgenbottam TW , Dinh-Xuan AT, Stone D, Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension . Lancet 1991; 338: 1173-74.

Frostell C. , Fratacci M. , Wain JC , Jones R. , Zapol WM Inhaled nitric oxides: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction . Circulation 1991; 83: 2038-47.